Addition of 1-3 mM-8-bromo-cyclic AMP to monolayer cultures of H-4 rat hepatoma cells resulted in a rapid but short-lived increase in tyrosine aminotransferase (EC 2.6.1.5) activity. The transient nature of this induction is due to desensitization to 8-bromo-cyclic AMP. Throughout this time course of induction and desensitization, removal of 8-bromo-cyclic AMP resulted in a rapid and significant decrease in tyrosine aminotransferase activity, a process referred to as 'de-induction' in this study. We showed that the changes in tyrosine aminotransferase activity in its induction, desensitization and de-induction by 8-bromo-cyclic AMP were directly attributable to changes in the synthesis rate of the protein, and the amount of translatable and hybridizable mRNA encoding for tyrosine aminotransferase (mRNATAT). We further showed that this desensitization was specific to cyclic AMP. First, only active analogues of cyclic AMP and agents which increased cellular concentrations of cyclic AMP elicited this desensitization. Second, the desensitized cells were refractory only to the effects of 8-bromo-cyclic AMP; dexamethasone and insulin induced the tyrosine aminotransferase activity in the 8-bromo-cyclic AMP-desensitized cells in a manner similar to that of the controls. Studies on the metabolism of 8-bromo-cyclic AMP suggest that neither its degradation nor the accumulation of its primary metabolite, 8-bromoadenosine, played a significant role in modulating the expression of tyrosine aminotransferase during the time course of action of 8-bromo-cyclic AMP. These results provide evidence for a specific pretranslational mode of action of cyclic AMP in the control of tyrosine aminotransferase expression in its desensitization and de-induction, in addition to the early phase of induction.
INTRODUCTION
The addition of an active analogue of cyclic AMP (e.g. dibutyryl cyclic AMP or 8-bromo-cycic AMP) to hepatoma-cell culture or its injection into rats causes a rapid and transient increase in the expression of tyrosine aminotransferase. We previously reported that 8-bromocyclic AMP increases the amount of translatable mRNATAT in H-4 rat hepatoma cells; this effect can account for the increase in the synthesis rate and activity of tyrosine aminotransferase during the early phase of induction of the enzyme [1] . Further direct evidence for a pretranslational mode of action of cyclic AMP in the regulation of tyrosine aminotransferase induction was obtained by using the cloned cDNATAT probe to quantify the amount of mRNATAT in rat liver after injections of dibutyryl cyclic AMP [2] . Finally, there is also evidence that dibutyryl cyclic AMP injected into rats causes a rapid increase in the transcription rate of mRNATAT as assayed in isolated rat liver nuclei run-off experiments [3] .
These results demonstrate that cyclic AMP increases the transcription rate of the tyrosine aminotransferase gene, and that this effect of cyclic AMP accounts for the early phase of induction of tyrosine aminotransferase activity in both rat liver and rat hepatoma cells. However, the biochemical event(s) subserving the transientness of the induction (whether exhaustion of the inducer, desensitization of the cells, or a secondary posttranscriptional effect of cyclic AMP on tyrosine aminotransferase expression) remains to be determined. For example, it has been reported that repeated injection of dibutyryl cyclic AMP into adrenalectomized rats modifies the translational activity of a basal amount of mRNATAT [4, 5] .
To gain a better understanding of the biochemical processes underlying the transitory nature of the cyclic AMP-evoked induction of tyrosine aminotransferase and to determine whether cyclic AMP has multiple, perhaps temporally separated, effects in the control of tyrosine aminotransferase expression, we examined the regulation of tyrosine aminotransferase expression by the addition and re-addition of 8-bromo-cyclic AMP to and its removal from H-4 hepatoma cells. We determined the rates of synthesis and degradation of tyrosine aminotransferase, and quantified the amount of translatable and hybridizable mRNATAT to evaluate if they, either singly or in combination, could account for the observed changes in tyrosine aminotransferase activity during its desensitization and de-induction, in addition to the early phase of induction. We [6] . T.l.c. plates used for the analysis of cyclic nucleotides were obtained from Eastman Kodak Co., Buffalo, NY, U.S.A., and were developed in a solvent system of butan-I-ol/acetic acid/water (5: 2: 3, by vol.). Rabbit antiserum against purified rat liver tyrosine aminotransferase was prepared as previously described [1] . Rabbit antiserum against rat liver phosphoenolpyruvate carboxykinase was generously supplied by Dr. P. lynedjian [7] . A slant ofEscherichia coli 5K harbouring the plasmid pcTAT-3, a 600-base-pair cDNA clone of tyrosine aminotransferase spliced into the Pstl site of pBR322, was kindly provided by Dr. Gunther Schutz of the German Cancer Research Centre, Heidelberg, Germany [2] . The phosphodiesterase inhibitor RO-1724/1 was a gift from Dr. W. E. Scott of Hoffmann-La Roche, Nutley, NJ, U.S.A. Forskolin was obtained from Calbiochem, San Diego, CA, U.S.A. Other chemicals and biochemicals, unless specified, were obtained from Sigma Chemical Co., St. Louis, MO, U.S.A. Tissue-culture supplies were obtained from Gibco, Grand Island, NY, U.S.A.
Cell culture
The H-4 rat hepatoma cell line is a derivative of line H4-II-E of Pitot et al. [8] , adapted to grow in vitro from the Reuber H-35 hepatoma. The cell line used in this study was Determination of the amount of mRNATAT by hybridization to 132PPcDNA probe A cDNA probe of tyrosine aminotransferase (pcTAT-3) was used to quantify the amount of hybridizable mRNATAT in a dot-blot analysis. The utility of the pcTAT-3 in determining the amount and size of mRNATAT has previously been published [2] .
Various amounts of RNA (up to 20 ,ug) in a constant volume (5 ,u) were spotted on to a 20 x SSC (1 x SSC = 0.15 M-NaCl/0.015 M-sodium citrate, pH 7.0)-pretreated and dried nitrocellulose membrane [16, 17] . The membrane was baked for 2 h at 80°C in vacuo and then incubated for 60 min at 45°C in a prehybridization mixture containing 5000 (v/v) formamide, 5 x TEN (1 x TEN = 10 mM-Tris, pH 7.4, 1 mM-EDTA and 100 mM-NaCl), 0.1 M-sodium phosphate (pH 7.0), 0.1 % sodium pyrophosphate, 0.1 % SDS, 50 ,ug of denatured salmon sperm DNA/ml; and 2.5 x Denhardt's solution (1 x Denhardt's solution = 0.2% each of bovine serum albumin, polyvinylpyrrolidone 360 and Ficoll 400) [18] . The membrane was then transferred to a hybridization solution composed of > 106 c.p.m. of denatured nick-translated pcTAT-3 (> 108 c.p.m./,#g of DNA)/ml and 10 % dextran in the prehybridization mixture supplemented with 1 x Denhardt's solution. Hybridization was carried out at 45°C overnight. The membrane was then washed three times at 50°C in 0.1 x TEN/0.1 % sodium pyrophosphate/1O mM-sodium phosphate (pH 7.0)/0.1 % SDS, followed by a wash at room temperature with 0.1 x TEN. The membrane was air-dried and exposed to X-ray film with an intensifying screen at -70 'C. For quantification of the relative amount of radioactivity of the dots, the fluorogram was scanned with a densitometer, and the 4600 readings were used to determine the relative abundance of mRNATAT. A control experiment comparing this densitometric method of measurement with the method of liquidscintillation spectrometry revealed a correlation coefficient of 0.998 for dots with < 0.8 A600 unit above the film's background.
Phosphodiesterase assay
Phosphodiesterase activity present in homogenates of the H-4 hepatoma cells was assayed by measuring the production of [3H]adenosine from cyclic [3H]AMP by methods previously described [19] (exogenous nucleotidase was used to cleave the phosphate from 5'-[3H]AMP, the inital product of the phosphodiesterase reaction when cyclic [3H]AMP was used as the substrate).
RESULTS
Fig . 1 depicts the time course of change in the activity and synthesis rate of tyrosine aminotransferase activity on the addition and re-addition of 8-bromo-cyclic AMP to, and its removal from, monolayer cultures of H-4 hepatoma cells. The result is representative of a large number of experiments carried out over a 1-year period. The addition of 1 mM-8-bromo-cyclic AMP to H-4 hepatoma cells resulted in a rapid and transient increase in the activity and synthesis of tyrosine aminotransferase ( Fig. 1) . Re-addition of fresh 8-bromo-cyclic AMP to the cell culture after the induction had reached a peak failed to evoke increases in the activity and synthesis of tyrosine aminotransferase in a manner comparable with that of the untreated cells (Fig. 1) . Furthermore, conditioned media recovered from cells at 16 h after addition of 1 mM-8-bromo-cyclic AMP, a time when tyrosine aminotransferase activity had fallen back to a basal value, induced tyrosine aminotransferase activity in control cell cultures (results not shown). Together, these results suggest that the transitory, rather than sustained, induction of tyrosine aminotransferase by 8--bromo-cyclic AMP is due to desensitization of the cells towards stimulation by 8-bromo-cyclic AMP. At all time points after the addition of 8-bromo-cyclic AMP, removal of the inducer gave a marked and rapid decrease in the activity and synthesis rate of tyrosine aminotransferase ( Fig. 1) , a process referred to as 'de-induction' in this study. Analysis of the turnover of tyrosine aminotransferase in control (t1 = 1.8 + 0.2 h), 8- Samples were processed for immunoprecipitation of tyrosine aminotransferase; the methods of immunoprecipitation and the specificity of the antiserum against tyrosine aminotransferase were previously described [1] . The bands other than the 50000-Da tyrosine aminotransferase were also observed when the immunoprecipitation reaction was done with the pre-immune serum [1] . 16 h after its addition and followed by incubation in inducer-free medium for an additional 2 and 6 h respectively (--Ai in Fig. lb; de-induced) . Corresponding changes in the activity of tyrosine aminotransferase at various time points after the addition (-) and re-addition ( 0) of 8-bromo-cyclic AMP to, and its removal from (--O), cultures of the H-4 hepatoma cells are illustrated in Fig. l(b) Fig. 1 . Total cytoplasmic RNA was isolated and translated in a message-dependent rabbit reticulocyte-lysate proteinsynthesis system as previously described [1] . The translation of mRNATAT and mRNAPEPCK to their respective protein products was monitored by the techniques of immunoprecipitation, SDS/polyacrylamide-gel electrophoresis and fluorography. The specificity of the phosphoenolpyruvate carboxykinase antiserum, provided by Dr. P. lynedjian, was previously described [7] . control of tyrosine aminotransferase expression in its induction, desensitization and de-induction is on the synthesis rather than the degradation of the protein.
In separate experiments, the amount of mRNA encoding tyrosine aminotransferase was determined by cell-free translation in a rabbit reticulocyte lysate system (Fig. 2) and by hybridization to a cDNA probe of tyrosine aminotransferase (Fig. 3) . Results showed that 8-bromo-cyclic AMP gave a rapid and transient increase in the amount of translatable (Fig. 2, samples 1-5) and hybridizable (Fig. 3, samples 1-5 (Fig. 3) .
Using a double-immunoprecipitation protocol with antibodies against tyrosine aminotransferase and phosphoenolpyruvate carboxykinase, we showed that 8- Table 1 show that only active analogues of cyclic AMP, including 8-bromo-cyclic AMP and dibutyryl cyclic AMP, and agents that increase cellular cyclic AMP concentration by activating adenylate cyclase and inhibiting phosphodiesterase, were able to evoke this desensitization phenomenon. Structurally related compounds, such as 5'-AMP (5 mM), butyrate (10 mM), cyclic AMP (1 mM) or 8-bromoadenosine (100,UM), had no effect either in inducing tyrosine aminotransferase or in evoking the desensitization of tyrosine aminotransferase induction towards 8-bromo-cyclic AMP. In addition, the results in Table 2 showed that the 8-bromo-cyclic AMPdesensitized cells were refractory only to homologous inducers (e.g. 8-bromo-cycic AMP or dibutyryl cyclic AMP); dexamethasone and insulin gave 2-4-fold increase in tyrosine aminotransferase activity in the desensitized cells, a magnitude comparable with that of the untreated controls.
The hydrolysis of cyclic AMP to 5'-AMP is catalysed by phosphodiesterase. In several previous studies, it was demonstrated that the activity of phosphodiesterase can undergo adaptive regulation. Cyclic AMP-mediated induction ofphosphodiesterase activity has been reported in L-cell fibroblasts [20] , 3T3 cells [21] , S-49 lymphoma cells [22] , C6 glioma cells [23] , astrocytoma cells [24] and AMP-pretreated neuroblastoma cells [25] . These results raise the possibility that enhanced metabolism of 8-bromo-cyclic AMP may account for, at least in part, the desensitization of tyrosine aminotransferase induction to 8-bromo-cyclic AMP. In this connection, we assayed for phosphodiesterase activity in extracts of control and 8-bromocyclic AMP-desensitized (1 mm for dependent decrease in both the basal and 8-bromo-cyclic AMP-induced tyrosine aminotransferase activity in H-4 hepatoma cells (Fig. 4) . The average concentration of 8-bromoadenosine, determined from five separate experiments, needed to give 50 % inhibition (I.0) of the 8-bromo-cyclic AMP-dependent increase in tyrosine aminotransferase activity was 135 #M. This concentration of 8-bromoadenosine was significantly higher than that found in the culture medium of cells incubated with 1 mM-8-bromo-cyclic AMP for 16 h (<20#M). In separate experiments, we determined that 8-bromoadenosine selectively increased the degradation rate of tyrosine aminotransferase without decreasing its rate of synthesis; the half-life of tyrosine aminotransferase in the control and in 100 ,iM-8-bromoadenosine-treated H4 cell cultures was 1.8 + 0.3 h and 0.9 + 0.2 h respectively. This effect of 8-bromoadenosine on the turnover of tyrosine aminotransferase may underlie its inhibition of tyrosine aminotransferase activity (Fig. 4 ). 8-Bromoadenosine had little or no effect on the general pattern and rate of total protein synthesis, nor did it significantly affect the degradation rate of total soluble proteins (results not shown).
Together, these results suggest that 8-bromo-cyclic AMP has a specific and intrinsic effect on the regulation of tyrosine aminotransferase expression during its induction, desensitization and de-induction, and that neither its degradation by phosphodiesterase nor the accumulation of its metabolite contributed significantly to the regulation of tyrosine aminotransferase expression under these conditions.
DISCUSSION
In this study, we present our observation of three temporally distinct effects of 8-bromo-cyclic AMP on the regulation of tyrosine aminotransferase expression in H-4 rat hepatoma cells; these effects are induction, desensitization and de-induction.
The possibility that the metabolism of 8-bromo-cyclic AMP and the accumulation of its metabolites account for or contribute to changes in tyrosine aminotransferase activity was investigated. There was no difference in the phosphodiesterase activity of control cells and of cells treated with 1 mM-8-bromo-cyclic AMP for 16 h (desensitized), suggesting that the transient induction of tyrosine aminotransferase activity and its desensitization cannot be attributed to enhanced degradation of the inducer. 8-Bromoadenosine was identified as the major, if not the only, catabolite of 8-bromo-cyclic AMP in both the medium and the extract of cells treated with 8-bromo-cyclic AMP, and it seemed possible that it could contribute to the observed transient induction and desensitization of tyrosine aminotransferase activity by 8-bromo-cyclic AMP. This hypothesis seemed particularly relevant, since at least some of the biological effects of cyclic nucleotides have been shown to be attributed to their metabolites. For example, the growth-inhibitory effects of dibutyryl cyclic AMP in hepatoma cells is primarily attributable to its adenosine catabolites [26] . In another study, it was reported that the 5'-AMP derivatives of both 8-bromo-cyclic AMP and N-monobutyryl cyclic AMP are as potent as the cyclic nucleotides in inhibiting growth of six different cell lines [27] . In our study, we found that pharmacological doses of 8-bromoadenosine increased the turnover rate of tyrosine aminotransferase. In addition, we found that the following compounds, listed in an order of decreasing potency, inhibited tyrosine aminotransferase activity and increased the degradation of the enzyme in a manner similar to that of 8-bromoadenosine: papaverine > 8-bromoadenosine > N6-(L-2-phenylisopropyl)adenosine = 8-bromo -AMP > 3-isobutyl-1-methylxanthine = adenosine. The inclusion of 5/#M-erythro-9-(2-hydroxy-3-nonyl)adenine, a potent inhibitor of adenosine deaminase, had no effect by itself, but potentiated the effects of adenosine in inhibiting tyrosine In our analysis, we found that the 8-bromo-cyclic AMP-evoked changes in tyrosine aminotransferase activity in its induction, desensitization and de-induction can be directly attributed to corresponding changes in its rate of synthesis and in the amount of mRNATAT. Our results do not provide evidence for a translational effect ofcyclic AMP in the control of tyrosine aminotransferase expression. Furthermore, the possibility that cyclic AMP may have temporally separated effects on the pretranslational and translational events of tyrosine aminotransferase expression [4, 5] cannot be supported by the results of this study. The thesis of a pretranslational regulation of tyrosine aminotransferase expression by 8-bromo-cyclic AMP is also supported by corresponding changes in the amount of translatable message encoding phosphoenolpyruvate carboxykinase under these experimental conditions. Previous studies from several laboratories have provided clear evidence that cyclic AMP exerts its primary effect on phosphoenolpyruvate carboxykinase induction at the nuclear, gene-transcription, level [30] [31] [32] .
It has not escaped our attention that the desensitization of tyrosine aminotransferase induction may be attributable to changes in the amount and activity of cyclic AMP-dependent protein kinase. Quantification of the regulatory and catalytic subunits of cyclic AMP-dependent kinase showed significant decreases in extracts obtained from 8-bromo-cyclic AMP-treated H-4 hepatoma cells as compared with that of the untreated control. Thus the amounts of the regulatory-subunit protein, as determined by the photoactivated incorporation of 8-azido-cyclic [32P]AMP, in cytosol of H-4 cells pretreated with 1 mM-8-bromo-cyclic AMP for 4 and 16 h, were 65 % and 32 % of that of the untreated control respectively. The corresponding values for the catalyticsubunit protein, assayed by the total amount of cyclic AMP-dependent phosphotransferase activity, were 40 % and 20 % ofthat ofthe untreated control. It is conceivable that this decrease in cytosolic cyclic AMP-dependent protein kinase may underlie the attenuated induction of tyrosine aminotransferase by 8-bromo-cyclic AMP in cells that were pretreated with the analogue. However, our analysis was limited to cytosolic cyclic AMPdependent protein kinase; the possibilities that the kinase may be translocated from the cytosol to nuclear fraction, or that the decrease in cytosolic cyclic AMPdependent protein kinase may represent an artifact in vitro, need to be carefully evaluated.
